In mid-September 2026, we tested a number of substances of particular concern to public health as part of our mobile and stationary drug-checking services. The active ingredient was once again found in two tablets believed to be ecstasy. PMMA analysed. Two tablets contained 4-fluorocathinone Instead of MDMA, another pill contained not only MDMA but also NEP detected. Furthermore, the majority of the other tablets sold as ecstasy contained either MDMA in addition to, or instead of, Caffeine resp. Mixtures of Amphetamine and caffeine. The majority of the samples sold as 3-MMC or 4-MMC contained the active ingredient 4-CMC or mixtures of 4-MMC and 4-BEC.

Under the following link, all samples that have been analysed by checkit! since the last warnings and classified as high-dose, unexpected or of particular health concern are presented in detail: Current warnings for calendar week 39 – 2026

From mid-August to early September 2026, we tested a number of substances of particular concern to public health as part of our in-person drug-checking service. The active ingredient was once again found in two tablets PMMA analysed. In a sample supplied as cocaine, only the active ingredient NEP/N-ethylpentedrone detected. In the majority of samples sold as 3-MMC, the active ingredient 4-CMC found.

Under the following link, all samples that have been analysed by checkit! since the last warnings and classified as high-dose, unexpected or of particular health concern are presented in detail: Current warnings for calendar week 37 – 2026

In mid-August 2026, we tested a range of substances posing a particular health risk. Several tablets submitted for analysis as ‘ecstasy’ contained a high or very high dose of MDMA. In some cocaine samples, cutting agents such as Levamisole, Procaine and/or Caffeine It was found that a tablet sold as alprazolam contained, instead, Flualprazolam. One GHB sample also contained GBL and 2 unknown substances.
In some of the samples submitted as 3-MMC and 4-MMC, it was not the expected cathinone that was found, but another cathinone, including 4-CMC, 4-MMC, N-Ethylpentedron and 4-BEC identified. A sample labelled as CBD contained an unspecified a specific semi-synthetic cannabinoid.

Under the following link, all samples that have been analysed by checkit! since the last warnings and classified as high-dose, unexpected or of particular health concern are presented in detail: Current warnings for calendar week 35 – 2026

In late July / early August 2026, we tested a number of substances of particular concern to public health as part of our mobile and stationary drug-checking services. In several tablets submitted for analysis as ‘ecstasy’, in addition to or instead of MDMA, Caffeine were found. A number of other ecstasy tablets contained a high or very high dose of MDMA. In some cocaine samples, cutting agents such as Levamisole, Procaine and/or Phenacetin was found. The majority of the samples submitted as 3-MMC and 4-MMC did not contain the expected cathinone, but rather a different cathinone, including 3-CMC, 4-CMC and N-Ethylpentedron.

Under the following link, all samples that have been analysed by checkit! since the last warnings and classified as high-dose, unexpected or of particular health concern are presented in detail: Current warnings, calendar week 33 – 2026

Several tablets sold as ecstasy contained ingredients other than the expected MDMA. One tablet contained PMMAanother N-Ethylpentedron and another tablet contained, instead of MDMA, a unknown substance. In a sample submitted as cannabis, the synthetic cannabinoids MDMB-INACA, ADB-4en-PINACA, MDMB-4en-PINACA, 5F-MDMB-PINACA identified. A sample submitted as cocaine contained only Procaine. Furthermore, cathinone was detected in both a sample submitted as 3-MMC and one submitted as 4-MMC N-Ethylpentedron identified. A substance sold as ‘Tusibi – pink Cocaine’ contained, in addition to MDMA, Ketamine, Caffeine and 2C-B also a unknown substance.

Under the following link, all samples that have been analysed by checkit! since the last warnings and classified as high-dose, unexpected or of particular health concern are presented in detail: Current warnings, calendar week 31 – 2026